Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed2
Other3

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT05944562Phase 1Active Not Recruiting
Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
Mycosis FungoidesMycosis Fungoides/Sezary SyndromeSezary Syndrome
PrincipalinvestigatorStart date: 2024-01-09
NCT06040320Phase 1/2Active Not Recruiting
Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)
Post-transplant Lymphoproliferative Disorder
PrincipalinvestigatorStart date: 2023-10-04
NCT04462328Phase 1Active Not Recruiting
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
Primary Central Nervous System Lymphoma
PrincipalinvestigatorStart date: 2021-04-29
NCT03297697Completed
Minimal Residual Disease in Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
StudychairStart date: 2017-07-31
NCT02181218Phase 1Completed
Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
Hodgkin DiseaseLymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Cutaneous+1 more
PrincipalinvestigatorStart date: 2015-02-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mitchell Cairo, MD

New York Medical College

Related
14 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Washington University School of Medicine
Similarity Score10%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffusePrimary Central Nervous System Lymphoma
Similarity Score7%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseHodgkin Disease

Worked with same sponsors:

CelgeneWashington University School of Medicine
Similarity Score7%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large B-Cell, Diffuse
Similarity Score7%

Hongmei Jing

Peking University Third Hospital

Related
4 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral
Similarity Score7%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, T-Cell, Peripheral
Similarity Score7%

Pier Luigi Zinzani, MD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Related
14 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseHodgkin Disease
Similarity Score7%

Jun Zhu, MD

Peking University Cancer Hospital & Institute

Related
12 trials

Shared therapeutic areas:

Lymphoma, T-Cell, PeripheralPrimary Central Nervous System Lymphoma
Similarity Score7%

Ye Guo, MD

Fudan University

Related
13 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseHodgkin Disease
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05944562Phase 1PrincipalInvestigator

Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome

Mycosis FungoidesMycosis Fungoides/Sezary SyndromeSezary Syndrome
Active Not Recruiting
NCT06040320Phase 1/2PrincipalInvestigator

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Post-transplant Lymphoproliferative Disorder
Active Not Recruiting
NCT04462328Phase 1PrincipalInvestigator

Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma
Active Not Recruiting
NCT03297697StudyChair

Minimal Residual Disease in Peripheral T-cell Lymphoma

Peripheral T Cell Lymphoma
Completed
NCT02181218Phase 1PrincipalInvestigator

Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

Hodgkin DiseaseLymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Cutaneous+1 more
Completed

All 5 trials loaded